Correlation of Ferritin and Transferrin Serum with hsCRP and F2-Isoprostane in Metabolic Syndrome
Abstract
BACKGROUND: The low inflammatory state that accompanies the Metabolic Syndrome (MetS) associates with the overexpression of oxidative stress. Ferritin and Transferrin serum are often used to measure iron status and their concentrations are altered in several metabolic conditions. We hypothesized that concentration of Ferritin and Transferrin serum increase in Metabolic Syndrome (MetS) and correlate with the inflammation and oxidative stress.
METHODS: We studied 65 male MetS patients, aged 43.26±7.16 years. Iron metabolism was measured by concentration of Ferritin and Transferrin serums, while inflammatory and oxidative stress by high sensitivity C-reactive Protein (hsCRP) and F2-Isoprostane.
RESULTS: Concentration of Ferritin 315.70±188.63 ng/L and Transferrin 2.36±0.31 g/L increased along with increasing components of MetS. Concentration of Ferritin serum had a positive correlation with hsCRP (r=0.220) and F2-Isoprostane (r=0.023).
CONCLUSION: Serum concentration of Ferritin increased in the MetS and correlates with hsCRP and F2-Isoprostane.
KEYWORDS: metabolic syndrome, ferritin, transferrin, hsCRP, F2-isoprostane
Full Text:
PDFReferences
Grundy S, Brewer B, Cleeman Jl, Smith S, Lenfant C. Definition of metabolic syndrome, report of National Heart, Lung and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation. 2004; 109: 433-8, CrossRef.
International Diabetes Federation. The IDF Consensus Worldwide Definition of The Metabolic Syndrome. Berlin; IDF: 2005, article.
Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJP. Cardiovascular metabolic syndrom? An interplay of obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes Metab. 2007; 9: 218-32, CrossRef.
Jose Manual F, Abel Lopez Bermejo, Wifredo Richart. Cross talk between iron metabolisme and diabetes. Diabetes Care. 2002; 51: 2348-54, CrossRef.
Moirand R, Mortaji A, Lore´al O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet. 1997; 349: 95-, CrossRef.
Festa A, D’Agostino R Jr, Tracy RP, Haffner. SM Elevated level of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes. Circulation. 2002; 5; 1131-7, CrossRef.
Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yukio T, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114: 1752-61, CrossRef.
Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999; 341: 1986-95, CrossRef.
Sibille JC, Kondo G, Aisen P. Interaction between isolated hepatocytes and kupffer cells in iron metabolism; a possible role for ferritin as an iron carrier protein. Hepatology. 1988; 8: 296-301, CrossRef.
Fernandez-Real J-M, Ricart-Engel W, Arroyo E, Balanca R, Casamitjana-Abella R, Cabrero D, et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care. 1998; 21: 62-8, CrossRef.
Kalantar-Zadeh K, Rodriguez RA, Humphreys MH. Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrology Dialysis Transplantation. 2004; 19: 141-9, CrossRef.
Istvan SV, Balkau B, Kettaneh A. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in general population. Diabetes Care. 2007; 30: 1795-801, CrossRef.
Fumeron F, Frank Pinn, Fatti Dris, Beverly Balkau, Jean Tichet, Michel Marre, et al. Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years. Diabetes Care. 2006; 29: 2090-4, CrossRef.
Wrede CE. Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur J Endocrinol. 2006; 154: 333-40, CrossRef.
Juckett MB, Balla J, Balla G, Jessurun J, Jacob HS, Vercellotti GM. Ferritin protects endothelial cells from oxidized low density lipoprotein in vivo. Am J Pathol. 1995; 147: 782-9, PMID.
DOI: https://doi.org/10.18585/inabj.v2i3.127
Copyright (c) 2010 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
